A mutation in the dynein heavy chain gene compensates for energy deficit of mutant SOD1 mice and increases potentially neuroprotective IGF-1

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Fergani, Anissa ^a,b   Eschbach, Judith ^a,b   Oudart, Hugues ^b,c   Larmet, Yves ^a,b   Schwalenstocker, Birgit ^d   Ludolph, Albert C ^d   Loeffler, Jean Philippe ^a,b   Dupuis, Luc ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c IPHC   (France)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DYNEIN ADENOSINE TRIPHOSPHATASE; FATTY ACID; MESSENGER RNA; SOMATOMEDIN C; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS BREEDING; DIET RESTRICTION; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GENE MUTATION; HYPERMETABOLISM; LIVER; MOTONEURON; MOUSE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 79955097181     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-26     Document Type: Article

References (47)

1. Energy metabolism in amyotrophic lateral sclerosis. L Dupuis PF Pradat AC Ludolph JP Loeffler, Lancet Neurol 2010 10 1 75 82 21035400
2. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. A Fergani H Oudart JL Gonzalez De Aguilar B Fricker F Rene JF Hocquette V Meininger L Dupuis JP Loeffler, J Lipid Res 2007 48 1571 1580 10.1194/jlr.M700017-JLR200 17438338 (Pubitemid 47312018)
3. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. L Dupuis H Oudart F Rene JL Gonzalez de Aguilar JP Loeffler, Proc Natl Acad Sci USA 2004 101 11159 11164 10.1073/pnas.0402026101 15263088 (Pubitemid 38989600)
4. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. L Dupuis P Corcia A Fergani JL Gonzalez De Aguilar D Bonnefont-Rousselot R Bittar D Seilhean JJ Hauw L Lacomblez JP Loeffler V Meininger, Neurology 2008 70 1004 1009 10.1212/01.wnl.0000285080.70324.27 18199832 (Pubitemid 351451324)
5. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in Amyotrophic Lateral Sclerosis. J Dorst P Kühnlein C Hendrich J Kassubek AD Sperfeld AC Ludolph, J Neurol 2010 258 4 613 7 21128082
6. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. D Kieran M Hafezparast S Bohnert JR Dick J Martin G Schiavo EM Fisher L Greensmith, J Cell Biol 2005 169 561 567 10.1083/jcb.200501085 15911875 (Pubitemid 41002849)
7. A dynein mutation attenuates motor neuron degeneration in SOD1(G93A) mice. M Teuchert D Fischer B Schwalenstoecker HJ Habisch TM Bockers AC Ludolph, Exp Neurol 2006 198 271 274 10.1016/j.expneurol.2005.12.005 16427626 (Pubitemid 43243765)
8. Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. HS Ilieva K Yamanaka S Malkmus O Kakinohana T Yaksh M Marsala DW Cleveland, Proc Natl Acad Sci USA 2008 105 12599 12604 10.1073/pnas.0805422105 18719118
9. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. M Hafezparast R Klocke C Ruhrberg A Marquardt A Ahmad-Annuar S Bowen G Lalli AS Witherden H Hummerich S Nicholson,, et al. Science 2003 300 808 812 10.1126/science.1083129 12730604 (Pubitemid 36532118)
10. Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic Dynein heavy chain 1 gene. XJ Chen EN Levedakou KJ Millen RL Wollmann B Soliven B Popko, J Neurosci 2007 27 14515 14524 10.1523/JNEUROSCI. 4338-07.2007 18160659
11. Neurodegeneration mutation in cytoplasmic dynein alters its organization and dynein-dynactin and dynein-kinesin interactions. W Deng C Garrett B Dombert V Soura G Banks EM Fisher MP van der Brug M Hafezparast, J Biol Chem 2010
12. Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease. L Dupuis A Fergani KE Braunstein J Eschbach N Holl F Rene JL Gonzalez De Aguilar B Zoerner B Schwalenstocker AC Ludolph JP Loeffler, Exp Neurol 2009 215 146 152 10.1016/j.expneurol.2008.09.019 18952079
13. A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons. KE Braunstein J Eschbach K Rona-Voros R Soylu E Mikrouli Y Larmet F Rene JL Gonzalez De Aguilar JP Loeffler HP Muller, et al. Hum Mol Genet 2010
14. SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice. DC Rogers J Peters JE Martin S Ball SJ Nicholson AS Witherden M Hafezparast J Latcham TL Robinson CA Quilter EM Fisher, Neurosci Lett 2001 306 89 92 10.1016/S0304-3940(01)01885-7 11403965 (Pubitemid 32524305)
15. Mutations in cytoplasmic dynein lead to a Huntington's disease-like defect in energy metabolism of brown and white adipose tissues. J Eschbach A Fergani H Oudart JP Robin F Rene JL de Aguilar Y Larmet J Zoll M Hafezparast B Schwalenstocker,, et al. Biochim Biophys Acta 2010 1812 1 59 69 20887786
16. The legs at odd angles (Loa) mutation in cytoplasmic dynein ameliorates mitochondrial function in SOD1G93A mouse model for motor neuron disease. AM El-Kadi V Bros-Facer W Deng A Philpott E Stoddart G Banks GS Jackson EM Fisher MR Duchen L Greensmith,, et al. J Biol Chem 2010 285 18627 18639 10.1074/jbc.M110.129320 20382740
17. Estimation of energy expenditure, net carbohydrate utilization, and net fat oxidation and synthesis by indirect calorimetry: evaluation of errors with special reference to the detailed composition of fuels. G Livesey M Elia, Am J Clin Nutr 1988 47 608 628 3281434
18. Dietary-induced pre-translational control of rat fatty acid synthase. T Laux M Schweizer, Biochem J 1990 266 793 797 2327966 (Pubitemid 20103714)
19. High carbohydrate diet and starvation regulate lipogenic mRNA in rats in a tissue-specific manner. TS Kim HC Freake, J Nutr 1996 126 611 617 8598545
20. Changes in lipoprotein lipase activities in adipose tissue, heart and skeletal muscle during continuous or interrupted feeding. MC Sugden MJ Holness RM Howard, Biochem J 1993 292 Pt 1 113 119 8503837 (Pubitemid 23158969)
21. Lipoprotein lipase and hepatic lipase in Wistar and Sprague-Dawley rat tissues. Differences in the effects of gender and fasting. X Galan M Llobera I Ramirez, Lipids 1994 29 333 336 10.1007/BF02537186 8015363 (Pubitemid 24149946)
22. IGF-I prevents glutamate-induced motor neuron programmed cell death. AM Vincent BC Mobley A Hiller EL Feldman, Neurobiol Dis 2004 16 407 416 10.1016/j.nbd.2004.03.001 15193297 (Pubitemid 38765100)
23. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. BK Kaspar J Llado N Sherkat JD Rothstein FH Gage, Science 2003 301 839 842 10.1126/science.1086137 12907804 (Pubitemid 36962626)
24. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. G Dobrowolny C Giacinti L Pelosi C Nicoletti N Winn L Barberi M Molinaro N Rosenthal A Musaro, J Cell Biol 2005 168 193 199 10.1083/jcb.200407021 15657392 (Pubitemid 40248217)
25. Adaptation of the growth hormone and insulin-like growth factor-I axis to chronic and severe calorie or protein malnutrition. MH Oster PJ Fielder N Levin MJ Cronin, J Clin Invest 1995 95 2258 2265 10.1172/JCI117916 7537760
26. Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration. RW Matheny BC Nindl ML Adamo, Endocrinology 2010 151 865 875 10.1210/en.2009-1217 20130113
27. Minireview: posttranscriptional regulation of the insulin and insulin-like growth factor systems. EK Lee M Gorospe, Endocrinology 2010 151 1403 1408 10.1210/en.2009-1123 20032049
28. Interactions of IGF-1 with the blood-brain barrier in vivo and in situ. W Pan AJ Kastin, Neuroendocrinology 2000 72 171 178 10.1159/000054584 11025411
29. Uptake of circulating insulin-like growth factor-I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF-II mRNA content in diabetic rat brain. CS Armstrong L Wuarin DN Ishii, J Neurosci Res 2000 59 649 660 10.1002/(SICI)1097-4547(20000301)59:5<649::AID-JNR83.0.CO;2-W 10686593 (Pubitemid 30133927)
30. Insulin-like growth factors cross the blood-brain barrier. RR Reinhardt CA Bondy, Endocrinology 1994 135 1753 1761 10.1210/en.135.5.1753 7525251 (Pubitemid 24363863)
31. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS. T Nishijima J Piriz S Duflot AM Fernandez G Gaitan U Gomez-Pinedo JM Verdugo F Leroy H Soya A Nunez I Torres-Aleman, Neuron 2010 67 834 846 10.1016/j.neuron.2010.08.007 20826314
32. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. S Garbuzova-Davis S Saporta E Haller I Kolomey SP Bennett H Potter PR Sanberg, PLoS One 2007 2 1205 10.1371/journal.pone.0001205 18030339
33. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Z Zhong R Deane Z Ali M Parisi Y Shapovalov MK O'Banion K Stojanovic A Sagare S Boillee DW Cleveland BV Zlokovic, Nat Neurosci 2008 11 420 422 10.1038/nn2073 18344992 (Pubitemid 351441888)
34. Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice. H Narai I Nagano H Ilieva M Shiote T Nagata T Hayashi M Shoji K Abe, J Neurosci Res 2005 82 452 457 10.1002/jnr.20668 16235250 (Pubitemid 41579344)
35. Immunohistochemical localization of insulin-like growth factor binding protein 2 in the central nervous system of SOD1(G93A) transgenic mice. SE Sim YH Chung JH Jeong SW Yun HS Lim D Kim SS Kim WB Lee CI Cha, J Mol Histol 2009 40 157 163 10.1007/s10735-009-9219-0 19468844
36. Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice. J Svensson M Diez J Engel C Wass A Tivesten JO Jansson O Isaksson T Archer T Hokfelt C Ohlsson, J Endocrinol 2006 189 617 627 10.1677/joe.1.06631 16731792 (Pubitemid 43922124)
37. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. JL Trejo J Piriz MV Llorens-Martin AM Fernandez M Bolos D LeRoith A Nunez I Torres-Aleman, Mol Psychiatry 2007 12 1118 1128 10.1038/sj.mp.4002076 17848918 (Pubitemid 350191366)
38. MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS. L Fang M Teuchert F Huber-Abel D Schattauer C Hendrich J Dorst H Zettlmeissel M Wlaschek K Scharffetter-Kochanek T Kapfer,, et al. J Neurol Sci 2010 294 51 56 10.1016/j.jns.2010.04.005 20441996
39. Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice. CP Soon PJ Crouch BJ Turner CA McLean KM Laughton JD Atkin CL Masters AR White QX Li, Neuromuscul Disord 2010 20 260 266 10.1016/j.nmd.2009.11.015 20097566
40. Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats. JE Puche M Garcia-Fernandez J Muntane J Rioja S Gonzalez-Baron I Castilla Cortazar, Endocrinology 2008 149 2620 2627 10.1210/en.2007-1563 18276748 (Pubitemid 351574499)
41. Extracellular growth factors and mitogens cooperate to drive mitochondrial biogenesis. P Echave G Machado-da-Silva RS Arkell MR Duchen J Jacobson R Mitter AC Lloyd, J Cell Sci 2009 122 4516 4525 10.1242/jcs.049734 19920079
42. Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. EJ Sorenson AJ Windbank JN Mandrekar WR Bamlet SH Appel C Armon PE Barkhaus P Bosch K Boylan WS David,, et al. Neurology 2008 71 1770 1775 10.1212/01.wnl.0000335970.78664.36 19029516
43. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice. E Teuling V van Dis PS Wulf ED Haasdijk A Akhmanova CC Hoogenraad D Jaarsma, Hum Mol Genet 2008 17 2849 2862 10.1093/hmg/ddn182 18579581
44. Bicaudal-D and its role in cargo sorting by microtubule-based motors. M Dienstbier X Li, Biochem Soc Trans 2009 37 1066 1071 10.1042/BST0371066 19754453
45. Bicaudal D2, dynein, and kinesin-1 associate with nuclear pore complexes and regulate centrosome and nuclear positioning during mitotic entry. D Splinter ME Tanenbaum A Lindqvist D Jaarsma A Flotho KL Yu I Grigoriev D Engelsma ED Haasdijk N Keijzer,, et al. PLoS Biol 2010 8 1000350 10.1371/journal.pbio. 1000350 20386726
46. ER Kandel JH Schwartz TM Jessell, Principles of neural science McGraw-Hill, New York 4 2000
47. Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. L Dupuis JL Gonzalez de Aguilar A Echaniz-Laguna J Eschbach F Rene H Oudart B Halter C Huze L Schaeffer F Bouillaud JP Loeffler, PLoS One 2009 4 5390 10.1371/journal.pone.0005390 19404401